Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Predictive Oncology Inc.’s (NASDAQ: POAI) TumorGenesis Partners with Cellevate for New Approach to Ovarian Cancer

Collaboration will use TumorGenesis’ expertise in cancer cell culture growth media in combination with Cellevate’s specialty in emerging field of nanofiber matrixes. Cutting-edge technology can help avoid mistakes in $2.6 billion process of bringing new drugs through FDA process. Coupling companies’ technology will give researchers ability to grow ovarian cancer tissues in 3D matrix support […]

11th Annual Medical Device Strategic Pricing & Accounts Conference To Share Best Practices For Value Proposition Development

Date: June 22-24, 2021 Virtual Event The 11th Annual Medical Device Strategic Pricing & Accounts Conference is being held from June 22-24, 2021, at Q1 Productions dynamic virtual platform. Companies, representatives, and professionals from the Medtech industry are invited to attend this virtual event. Operating since 2006, Q1 Productions specializes in delivering educational programming through […]

Knightscope Inc.’s Growing Client Base and its Quest to Make the United States the Safest Nation in the World

Knightscope Inc. has seen a 46% drop in reported crime at one location and has operated over 1,000,000 hours of service for its autonomous security robots nationwide The versatility of the robots have seen their deployment in various areas such as airports, manufacturing plants, hospitals, stadiums, residential and commercial properties Recently, the Grand Sierra Resort […]

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Gains Inclusion on Russell 2000 Index as Brain Cancer Trial Enrollment Advances

Brain cancer drug developer CNS Pharmaceuticals is actively enrolling patients for a potentially pivotal Phase 2 trial of the company’s lead drug candidate, Berubicin, a promising candidate for treating a devastating condition CNS’s focus has been on developing a means of combating glioblastoma, a fatal, generally incurable class of brain cancers that are aggressive and […]

Save Foods Inc. (NASDAQ: SVFD) Is ‘One to Watch’

The agricultural produce treatment space has been active in recent years, attracting more than $26 billion in new investment in 2020 In May 2021, Save Foods Inc. closed on a $12 million public offering and uplisted its shares to the Nasdaq The company has seen rapid movement from successful pilots with packing houses and food […]

BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Focused on Building Leading U.S. Ecosystem

Recent agreements have been strategic steps taken by BEV to position itself in growing U.S. market Agreements involve key manufacturing, distribution, fulfillment partners TRACE products feature the company’s alkaline, plant-based mineral beverages and nutraceuticals Committed to creating a powerful ecosystem focused on developing and manufacturing alkaline, plant-based, and cannabinoid beverages and supplements, BevCanna Enterprises (CSE: […]

6th Annual Medical Device Human Factors & Usability Conference To Offer Unique Strategies and Effective Design Roadmaps

June 22-24, 2021 Virtual Event The 6th Annual Medical Device Human Factors & Usability Conference will be held from June 22-24, 2021, at the Q1 Productions dynamic virtual platform. Companies, representatives, and professionals from the Medical Device, Diagnostic and Combination products industry are invited to attend this virtual event. Operating since 2006, Q1 Productions specializes […]

Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) Making Advances in Bladder Cancer Treatment Through Proprietary Imaging Technology

Company’s i/Blue Imaging System(TM) is expected to be completed in 2022 The American Cancer Society estimates that 2021 will see 83,370 new cases of bladder cancer and approximately 17,200 deaths More than half of the patients who underwent a cystoscopy to remove non-muscle-invasive bladder cancer will experience recurrence The bladder cancer market was valued at […]

 

From Our Blog

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Advancing Early Detection, Tackling Heart Disease Through AI and Biomarker Insights

May 1, 2026

Cardiovascular disease continues to place a profound burden on individuals, economies and healthcare systems worldwide, affecting millions of lives while driving substantial medical costs and resource demands. Cardio Diagnostics Holdings (NASDAQ: CDIO) is committed to reducing the impact of heart disease by developing a platform that integrates artificial intelligence and epigenetic and genetic biomarkers to deliver personalized […]

Rotate your device 90° to view site.